Phagos
PrivateLast Round
Series A
Oct 8, 2025
Total Funding Raised
$31.4M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Phagos is a biotechnology company that develops AI-driven bacteriophage therapies to combat bacterial diseases, initially focusing on animal health.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Phagos Comparables
Compare Phagos with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PhageLab | 87% | |
| Proteon Pharmaceuticals | 84% | |
| Sciphage | 76% |
Phagos Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 8, 2025 | ||||
| Seed | Sep 27, 2022 |
Key People
Founding team and executive leadership
Phagos Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CapHorn Invest | Series A |
| Hoxton Ventures | Series A, Seed |
| Founders Capital | Series A |
| Acurio Ventures | Series A |
| AgFunder | Series A, Seed |
| Entrepreneurs First | Series A, Seed |
| Citizen Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 1, 2026
Open roles increased to 61, 81% of headcount.
- Jul 20, 2026
Open roles increased to 30, 41% of headcount.
Phagos Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Phagos's valuation, stock price, and market status.
Is Phagos a public or private company?
Phagos is a private company.
What is the current stock price of Phagos?
Phagos is a private company with no public stock price. No recent secondary market data is available.
How much is Phagos worth (valuation)?
Valuation information for Phagos is not publicly available.
Can I buy Phagos stock?
Phagos shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Phagos's last funding round?
Phagos's most recent funding round was Series A on October 9, 2025.
Who are the main investors in Phagos?
Key investors in Phagos include CapHorn Invest, Hoxton Ventures, Capagro, Demea Sustainable Investment.
Will Phagos IPO soon?
No public IPO plans have been announced for Phagos.
How can I track Phagos secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Phagos's secondary market activity and sign up for updates.